Parinaud's oculoglandular syndrome (POS) is a disease characterized by a combination of symmetrical inflammation of the salivary and lacrimal glands, as well as enlargement of regional lymph nodes. The main cause of the syndrome is an infection associated with viruses, bacteria or parasites, which can cause qualitative changes in the ocular and visual systems, leading to visual impairment. Clinically, the syndrome can manifest itself against the background of conjunctivitis, paralysis and dysfunction of the lacrimal glands, and is often associated with systemic reactions such as fever, headache and general weakness. POS requires a comprehensive approach to diagnosis and treatment, including an assessment of all existing symptoms and their relationship with possible etiologic factors.
History of the disease and interesting historical facts
Parinaud's oculoglandular syndrome was first described in the early 20th century, when its clinical manifestations began to be associated with various infectious diseases. An important contribution to the study of this syndrome was the work of the French ophthalmologist Georges Parinaud, who systematized data on clinical manifestations and disorders associated with inflammation of the lacrimal and salivary glands.
Although AGS has remained a subject of interest for a narrow group of specialists for many years, its importance has increased significantly in recent decades amid the increase in viral infections such as epidemic conjunctivitis and autoimmune diseases. Some studies show that during outbreaks of infectious diseases such as influenza or COVID-19, the number of AGS cases increases, which requires additional attention from doctors and scientists.
Epidemiology
The epidemiology of Parinaud's oculoglandular syndrome remains relatively poorly understood, but some data suggest that its prevalence ranges from 0.5 to 3.5 cases per 10,000 visits to the health care system. Prevalence may vary by region and time of year, peaking during cold and flu seasons. Of particular note is that although the syndrome can occur in patients of all ages, it is more common in children and the elderly, especially in settings with increased exposure to infectious agents.
Genetic predisposition to this disease
To date, genetic predisposition to Parinaud's oculoglandular syndrome remains an area of active research. Studies show that certain genes responsible for the immune response may be involved in the pathogenesis of this disease. Some associations have been shown between polymorphisms of genes encoding proinflammatory cytokines and an increased predisposition to the development of OGS. In particular, mutations in the TNF-α and IL-6 genes may affect the severity of clinical manifestations and predispose to more severe forms of bradycardia in concomitant infections.
Risk factors for the development of this disease
Risk factors for Parinaud's oculoglandular syndrome include:
- Individual factors: genetic predisposition, chronic diseases, immunodeficiencies.
- Physical factors: prolonged exposure to ultraviolet radiation, mechanical injuries to the eye area.
- Chemical factors: exposure to toxic substances, allergens, irritants in the form of chemical solutions and vapors.
- Infectious agents: the presence of contact infections such as viral and bacterial infections, which are often encountered in public settings.
- Social factors: age (children and the elderly are more at risk) and living conditions (e.g. living in crowded spaces).
Diagnosis of this disease
The diagnosis of Parinaud's oculoglandular syndrome is based on a combination of clinical symptoms and additional examination results. The main symptoms of OGS include:
- conjunctivitis with severe hyperemia and exudation;
- enlarged lymph nodes in the neck and submandibular region;
- dysfunction of the lacrimal glands (dryness or excessive lacrimation).
Laboratory tests may include a complete blood count, which will show signs of inflammation (increased white blood cell count, left shift in the formula). Radiological examinations, such as ultrasound or CT, may reveal enlarged salivary glands and the condition of the lymph nodes. It is important to differentiate OGS from other ophthalmological and infectious diseases, such as allergic conjunctivitis, lymphogranulomatosis, and some types of syphilis.
Treatment
Treatment for Parinaud's oculoglandular syndrome is often multifaceted and individualized, aimed at reducing inflammation and relieving symptoms. General treatment principles include:
- Pharmacological treatment: use of anti-inflammatory and analgesic drugs, antihistamines; in some cases, antibiotics and antiviral drugs are prescribed.
- Surgical treatment may be required in complicated cases, such as when abscesses form or when enlarged lymph nodes need to be drained.
- Supportive therapy, including the use of artificial tears to improve comfort in patients with lacrimal gland dysfunction.
- Physical therapy and systematic work with a speech therapist to restore functions after inflammatory processes in the eye area.
List of medications used to treat this disease
Among the medications used to treat Parinaud's oculoglandular syndrome are:
- Diclofenac is an anti-inflammatory drug.
- Levofloxacin is a broad-spectrum antibiotic.
- Dexamethasone is a glucocorticosteroid used to reduce inflammation.
- Tobrex is a topical antibiotic for bacterial eye infections.
- Artificial tears - to moisturize and protect the cornea.
Disease monitoring
Monitoring of Parinaud's oculoglandular syndrome includes regular observation of the patient's condition, control of the dynamics of clinical manifestations and possible side effects from the treatment. The prognosis with early diagnosis and adequate therapeutic intervention is usually favorable, but complications such as chronic conjunctivitis or dry eye syndrome are possible. The need to monitor the condition should be remembered, as this reduces the risk of chronic forms of the disease.
Age-related features of the disease
Parinaud's oculoglandular syndrome may present differently in different age groups. In children, the disease most often causes acute clinical manifestations, symptoms may include fever and general malaise, as well as a rapid response to treatment. In older people, the disease may proceed more covertly, with less pronounced symptoms or in the form of exacerbations of concomitant diseases. In this case, a long course and a risk of complications are observed.
Questions and Answers
- What is Parinaud's oculoglandular syndrome? – This is a syndrome associated with inflammation of the lacrimal and salivary glands, as well as enlargement of the lymph nodes, caused by infectious agents.
- What are the main symptoms of OGS? – The main symptoms include conjunctivitis, enlarged lymph nodes, dryness or excess tears.
- Is it possible to completely cure oculoglandular syndrome? – With timely diagnosis and adequate treatment, complete recovery is usually observed.
- How are diagnostic procedures performed for OGS? – Diagnosis includes examination, laboratory tests and radiological examinations to determine the condition of the lacrimal and salivary glands.
- What is the outlook for the disease with treatment? – The prognosis with adequate treatment is good, but monitoring the condition is necessary to prevent possible complications.
